IBS in 2010: Advances in pathophysiology, diagnosis and treatment

Nature Reviews Gastroenterology and Hepatology

Volumn 8, Issue 2, 2011, Pages 76-78

  Ford, Alexander C ^a   Talley, Nicholas J ^b  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

^b UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

KETOTIFEN; LINACLOTIDE; PLACEBO; TEGASEROD;

CEREBROVASCULAR DISEASE; COLON BIOPSY; COLONOSCOPY; CONSTIPATION; DIAGNOSTIC TEST; DIARRHEA; DRUG DOSE COMPARISON; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GENDER; HUMAN; INTESTINE INFECTION; IRRITABLE COLON; NERVE STIMULATION; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; WATER CONTAMINATION;

CENTRAL NERVOUS SYSTEM; COLONOSCOPY; GASTROINTESTINAL AGENTS; HUMANS; INTESTINAL DISEASES; IRRITABLE BOWEL SYNDROME; KETOTIFEN; PEPTIDES;

EID: 79751514491     PISSN: 17595045     EISSN: 17595053     Source Type: Journal    
DOI: 10.1038/nrgastro.2010.216     Document Type: Review

References (9)

1. Mertz, H. et al. regional cerebral activation in rritable bowel syndrome and control subjects with painful and nonpainful rectal distention. Gastroenterology 118, 842-848 (2000). (Pubitemid 30243747)
2. Bonaz, B. et al. Central processing of rectal pain in patients with irritable bowel syndrome: an fMri study. Am. J. Gastroenterol. 97, 654-661 (2002). (Pubitemid 34245894)
3. Tillisch, K., Mayer, E. A. & Labus, J. S. Quantitative meta-analysis identifies brain regions activated during rectal distension in rritable bowel syndrome. Gastroenterology doi:10.1053/j.gastro.2010.07.053 (2010).
4. Thabane, M., Kottachchi, D. & Marshall, J. K. Systematic review and meta-analysis: ncidence and prognosis of post-infectious rritable bowel syndrome. Aliment Pharmacol. Ther. 26, 535-544 (2007). (Pubitemid 47174284)
5. Marshall, J. K. et al. eight year prognosis of postinfectious irritable bowel syndrome following waterborne bacterial dysentery. Gut 59, 605-611 (2010).
6. Chey, W. D. et al. The yield of colonoscopy in patients with non-constipated irritable bowel syndrome: results from a prospective, controlled US trial. Am. J. Gastroenterol. 105, 859-865 (2010).
7. Lembo, A. J. et al. efficacy of linaclotide for patients with chronic constipation. Gastroenterology 138, 886-895 (2010).
8. Johnston, J. M. et al. Linaclotide improves abdominal pain and bowel habits in a phase iib study of patients with irritable bowel syndrome. Gastroenterology doi:10.1053/j. gastro.2010.08.041 (2010).
9. Klooker, T. K. et al. The mast cell stabiliser ketotifen decreases visceral hypersensitivity and improves intestinal symptoms in patients with irritable bowel syndrome. Gut 59, 1213-1221 (2010).